Advancements in oncoproteomics technologies: Treading toward translation into clinical practice
Proteomics continues to forge significant strides in the discovery of essential biological
processes, uncovering valuable information on the identity, global protein abundance …
processes, uncovering valuable information on the identity, global protein abundance …
A review of cancer data fusion methods based on deep learning
With advancements in modern medical technology, an increasing amount of cancer-related
information can be acquired through various means, such as genomics, proteomics …
information can be acquired through various means, such as genomics, proteomics …
The hidden story of heterogeneous B-raf V600E mutation quantitative protein expression in metastatic melanoma—association with clinical outcome and tumor …
In comparison to other human cancer types, malignant melanoma exhibits the greatest
amount of heterogeneity. After DNA-based detection of the BRAF V600E mutation in …
amount of heterogeneity. After DNA-based detection of the BRAF V600E mutation in …
Serum mass spectrometry proteomics and protein set identification in response to FOLFOX-4 in drug-resistant ovarian carcinoma
Simple Summary A mass spectrometry (MS) proteomics and molecular pathway study was
applied to serum samples of patients with ovarian serous carcinoma administered the …
applied to serum samples of patients with ovarian serous carcinoma administered the …
The Application of Artificial Intelligence in Lung Cancer Research
F Lei - Cancer Control, 2024 - journals.sagepub.com
The advent of artificial intelligence in healthcare is transforming medical research and
clinical practice, with significant advancements in the areas of oncology. This commentary …
clinical practice, with significant advancements in the areas of oncology. This commentary …
Betulinic acid affects the energy-related proteomic profiling in pancreatic ductal adenocarcinoma cells
CF Chiu, HY Chang, CY Huang, CZ Mau, TT Kuo… - Molecules, 2021 - mdpi.com
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with a 5-year survival
rate of< 8%. Therefore, finding new treatment strategies against PDAC cells is an imperative …
rate of< 8%. Therefore, finding new treatment strategies against PDAC cells is an imperative …
A State-of-the-Art Roadmap for Biomarker-Driven Drug Development in the Era of Personalized Therapies
V Serelli-Lee, K Ito, A Koibuchi, T Tanigawa… - Journal of Personalized …, 2022 - mdpi.com
Advances in biotechnology have enabled us to assay human tissue and cells to a depth and
resolution that was never possible before, redefining what we know as the “biomarker”, and …
resolution that was never possible before, redefining what we know as the “biomarker”, and …
Omics Applications in Cancer Immunology
Recent technological advances in molecular biology have led to great progress in the
knowledge of structure and function of cells and their main constituents. In this …
knowledge of structure and function of cells and their main constituents. In this …
Computational resources and chemoinformatics for translational health research.
T Tripathi, DB Singh - Advances in Protein Chemistry and Structural …, 2024 - europepmc.org
The integration of computational resources and chemoinformatics has revolutionized
translational health research. It has offered a powerful set of tools for accelerating drug …
translational health research. It has offered a powerful set of tools for accelerating drug …
DARTS metoda proteomike u istraživanju bioloških meta erlotiniba
M Finek - 2024 - repository.biotech.uniri.hr
Sažetak Proteomika je jedna od omics metoda koja istražuje funkcije, strukture i ekspresiju
svih proteina u biološkom sustavu. Ključna je za razumijevanje mehanizama bolesti, a …
svih proteina u biološkom sustavu. Ključna je za razumijevanje mehanizama bolesti, a …